« Previous
Next »
Fertility and Sterility
Volume 90, Issue 6
, Pages 2091-2098
, December 2008
Genetic evaluation of oocyte donors: recipient couple preferences and outcome of testing
References
- . Minimal genetic screening for gamete donors. Fertil Steril. 2002;77:S15–S16
- Practice Committee of the American Society for Reproductive Medicine; Practice Committee of the Society for Assisted Reproductive Technology. 2006 guidelines for gamete and embryo donation. Fertil Steril. 2006;86:S38–S50
- European Society of Human Genetics and European Society of Human Reproduction and Embryology. The need for interaction between assisted reproduction technology and genetics: recommendations of the European Societies of Human Genetics and Human Reproduction and Embryology. Hum Reprod. 2006;21:1071–1073
- . Attitudes about genetic risk of couples undergoing in-vitro fertilization. Hum Reprod. 1998;13:862–866
- . Disclosure decisions among pregnant women who received donor oocytes: a phenomenological study. Fertil Steril. 2007;87:288–296
- . Inclusion of heterozygotes for cystic fibrosis in the egg donor pool. Fertil Steril. 2002;78:557–561
- . Survey of genetic screening for oocyte donors. Fertil Steril. 1999;71:278–281
- American College of Obstetricians and Gynecologists Committee on Genetics. ACOG committee opinion. No. 338: Screening for fragile X syndrome. Obstet Gynecol. 2006;107:1483–1485
- . Acceptance of fragile X premutation genetic screening in women with ovarian dysfunction. Am J Obstet Gynecol. 2006;194:738–743
- Molecular fragile X screening in normal populations. Am J Med Genet. 1996;64:181–183
- High incidence of chromosomal abnormalities in oocyte donors. Fertil Steril. 2007;87:439–441
- Cryos International. Available at: http://www.cryosinternational.com/donor-semen/screening.aspx. Accessed on March 9, 2007.
- . Wrongful life and wrongful birth: legal aspects of failed testing in oocyte donation. Penn Bioeth J. 2005;1:1–4
- . Congenital disabilities and the law. Clin Perinatol. 2007;34:263–273
V.L.B. has received research support from Institute Biochimique (IBSA), Switzerland. H.M.R. is an employee of Fertility Physicians of Northern California. G.D.A. is CEO and a shareholder of Advanced Reproductive Care, Palo Alto, CA, and his spouse is a shareholder of Advanced Reproductive Care. G.D.A. is a physician and an owner of Fertility Physicians of Northern California, has received research support from IBSA, has been a speaker for Ferring Pharmaceuticals, Suffern, NY, and is on the LabCorp Advisory Board, Morrisville, NC.
PII: S0015-0282(07)03955-6
doi: 10.1016/j.fertnstert.2007.10.069
© 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 90, Issue 6
, Pages 2091-2098
, December 2008

